Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada

By cineramaFebruary 12, 2019Bitcoin Business

IBM Canada will provide the core blockchain tech behind tracking patient consent and engagement as well as for securing health data exchanges. (Getty/ismagilov) The Canada-based units of Boehringer Ingelheim […]

Click here to view full article

Previous PostFacebook Hires Chainspace Blockchain Experts Even With Cryptocurrency Price Decline
Next PostFuture Of Blockchain University Conference That Aims To Enlighten A Generation

You must be logged in to post a comment.

Disclaimer

The statements, opinions and data contained on this site are solely those of the individual authors and contributors and not of the publisher of www.bitcoinisle.com. All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured primarily from third party sources. We make no warranties of any kind in relation to our content and services, including but not limited to accuracy, security and updatedness. No part of the content and services that we provide constitutes financial advice, legal advice or any other form of advice. Any use or reliance on our content and services is solely at your own risk and discretion. You should conduct your own research, review, analyze and verify our content and services before relying on or using them. Participating in cryptocurrency activities is a highly risky endeavor, please therefore consult your financial advisor before making any monetary decisions. No content on our Site is meant to be a solicitation or offer.

Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada

Breaking News…

Previous PostFacebook Hires Chainspace Blockchain Experts Even With Cryptocurrency Price Decline

Next PostFuture Of Blockchain University Conference That Aims To Enlighten A Generation

Leave a Reply

Disclaimer